eMediNexus Coverage from: 
Progress in treatment of rare cancers named "Advance of the Year" by ASCO
Dr KK Aggarwal,  04 February 2019
remove_red_eye 617 Views

0 Read Comments                

The American Society of Clinical Oncology (ASCO) has named “Progress in Treating Rare Cancers” as the “Advance of the Year” in its annual Clinical Cancer Advances report released on Thursday.According to the report, rare cancers account for about 20% of all cancers diagnosed annually in the United States. But progress in their treatment has not kept pace with the more common types of the cancer.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!